Literature DB >> 729713

The validity of the estimates of the half-saturation concentration and maximum velocity for the efflux of glucose from human erythrocytes in infinite-cis conditions.

I A Nimmo.   

Abstract

It is shown that, if the asymmetrical model for glucose transport is correct, the published estimates of this half-saturation concentration must be low. As a result, the model is even less able than before to satisfy the tests of its validity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729713     DOI: 10.1007/bf02034666

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  7 in total

1.  Two-carrier models for mediated transport. I. Theoretical analysis of several two-carrier models.

Authors:  Y Eilam
Journal:  Biochim Biophys Acta       Date:  1975-09-02

2.  Determination of the temperature and pH dependence of glucose transfer across the human erythrocyte membrane measured by glucose exit.

Authors:  A K SEN; W F WIDDAS
Journal:  J Physiol       Date:  1962-03       Impact factor: 5.182

3.  An analysis of the adequacy of the asymmetric carrier model for sugar transport.

Authors:  D M Foster; J A Jacquez
Journal:  Biochim Biophys Acta       Date:  1976-06-04

Review 4.  Carrier and non-carrier models for sugar transport in the human red blood cell.

Authors:  W R Lieb; W D Stein
Journal:  Biochim Biophys Acta       Date:  1972-04-18

5.  Rejection criteria for the asymmetric carrier and their application to glucose transport in the human red blood cell.

Authors:  B L Hankin; W R Lieb; W D Stein
Journal:  Biochim Biophys Acta       Date:  1972-10-23

6.  Is there a high affinity site for sugar transport at the inner face of the human red cell membrane?

Authors:  W R Lieb; W D Stein
Journal:  J Theor Biol       Date:  1977-11-21       Impact factor: 2.691

7.  The kinetics of selective biological transport. I. Determination of transport constants for sugar movements in human erythrocytes.

Authors:  D M Miller
Journal:  Biophys J       Date:  1965-07       Impact factor: 4.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.